erdafitinib,cetrelimab,Vinflunine,Docetaxel,Pembrolizumab
janssen,pierre fabre,Merck
['urothelial', 'muc ,(-much)', 'ragnar', 'norse', 'erdafitinib', 'cetrelimab']
asco post #asco2023: #erdafitinib showing responses in multiple fgfr altered tumor types: 1 tumor agnostic p2 ragnar: 16 distinct solid #cancer types
2 p3 thor: metastatic/advanced #urothelialcancer vs chemo
3 p2 norse in combo with #cetrelimab for muc 
Prof. of Urology @LMU_Muenchen GU Oncology, Sports Medicine - Vice President R&D Bladder Cancer @JanssenGlobal 🚵‍♀️Passionate cyclist